|Bid||31.64 x 300|
|Ask||49.15 x 200|
|Day's Range||45.41 - 47.34|
|52 Week Range||37.35 - 55.38|
|PE Ratio (TTM)||-19.76|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|
Q1 2017 Neurocrine Biosciences Inc Earnings Call
During the week ended May 26, 2017, Alexion Pharmaceuticals (ALXN) saw the biggest loss in the healthcare sector. ALXN's stock price witnessed a steep fall of ~14.2%.
The biotech sector as measured by the iShares Nasdaq Biotech ETF is down another 1.40% today.